Symbioken is a French start-up company created in 2011. Symbioken has developed a device, named AmeaCell®, to be used by esthetic surgeons for their patients for wrinkles filling. AmeaCell® allows the extraction of both stem cells and matrix from the patient, for re-injection into the same patient’s face wrinkles for filling them and skin repair. The device is currently under clinical investigation.
| Website | http://www.symbioken.com |
| Revenue | $4 million |
| Employees | 2 (2 on RocketReach) |
| Founded | 2011 |
| Address | 42, Avenue du Général de Croutte, Toulouse, Occitanie 31100, FR |
| Technologies |
JavaScript
,
HTML
,
Google Analytics
+3 more
(view full list)
|
| Industry | Medical Devices, Business Services General, Business Services |
| Competitors | BioMarin Pharmaceutical Inc., Organogenesis, Genzyme Europe B.V., Integra LifeSciences, Acelity, Avacta, Kinex Medical Company, LLC, Tissue Regenix Group, MassChallenge, Bio-Rad Magyarország Kft. +36 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541713 Companies |
Looking for a particular SYMBIOKEN employee's phone or email?
SYMBIOKEN Questions
The SYMBIOKEN annual revenue was $4 million in 2026.
2 people are employed at SYMBIOKEN.
SYMBIOKEN is based in Toulouse, Occitanie.
The NAICS codes for SYMBIOKEN are [5417, 541, 54, 54171, 541713].
The SIC codes for SYMBIOKEN are [87, 873].
Top SYMBIOKEN Employees
-
Cynthia Cottereau
Quality and Regulatory Affairs Manager at SYMBIOKEN
Pensol, Nouvelle-Aquitaine, FR
